(Q40292246)

19 September 2017

title

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus (English)

1 reference

19 September 2017

1 reference

Christiane Stahl-Hennig

2

object named as

Christiane Stahl-Hennig

1 reference

19 September 2017

16

Klaus Uberla

1 reference

19 September 2017

3

Heribert Stoiber

1 reference

19 September 2017

1

Seraphin Kuate

1 reference

19 September 2017

6

Monika Franz

1 reference

19 September 2017

14

Ralph M Steinman

1 reference

19 September 2017

Godwin Nchinda

4

1 reference

19 September 2017

Anja Floto

5

1 reference

19 September 2017

Ulrike Sauermann

7

1 reference

19 September 2017

Simon Bredl

8

1 reference

19 September 2017

Ludwig Deml

9

1 reference

19 September 2017

Ralf Ignatius

10

1 reference

19 September 2017

Steve Norley

11

1 reference

19 September 2017

Paul Racz

12

1 reference

19 September 2017

Klara Tenner-Racz

13

1 reference

19 September 2017

Ralf Wagner

15

1 reference

19 September 2017

language of work or name

English

0 references

publication date

17 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

351

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

133-144

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Prospects for an AIDS vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

A novel approach for producing lentiviruses that are limited to a single cycle of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Transfer of primer binding site-mutated simian immunodeficiency virus vectors by genetically engineered artificial and hybrid tRNA-like primers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Mechanisms of protection against simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Specific and non-specific immunity and protection of macaques against SIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Increased non-viral gene transfer levels in mice by concentration of cationic lipid DNA complexes formed under optimized conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Accelerated clearance of SHIV in rhesus monkeys by virus-like particle vaccines is dependent on induction of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Experimental infection of macaques with HIV-2ben, a novel HIV-2 isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Anti-cell antibody in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.03.009

1 reference

release_zloh732zzzabpdmrnrijftwbnq

19 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zloh732zzzabpdmrnrijftwbnq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference